Abstract:Fructus Aurantii (FA) is the dry and immature fruit of Citrus aurantium L. and its rutaceous cultivars. FA has been widely used to treat digestive system diseases since ancient China, and it promotes gastrointestinal (GI) motility in functional dyspepsia (FD), but its potential therapeutic mechanisms remain unclear. We examined the effects of FA ethanol extracts in an iodoacetamide (IA)-induced FD rat model. Firstly, key FA therapy targets for FD were gathered using systematic pharmacology. Combined with systemic pharmacological analyses, plasma metabolomics based on UPLC-QTOF-MS were conducted. Then, MetaboAnalyst was used to jointly analyze systemic pharmacology targets and metabolomic metabolites to select key metabolic pathways. Finally, the key path is verified by experiments. FA exerted distinct therapeutic effects in anti-inflammation and promoting gastrointestinal motility in our IA-induced FD rat model. When compared with the model group, FA down-regulated the inflammatory factors interleukin 1β and tumor necrosis factor-α. At the same time, FA up-regulated tight junction proteins in the intestinal epithelial barrier. Through the integrated analysis of metabolomics and systemic pharmacology, we conducted experimental verification on Fc epsilon RI signaling pathway. When compared with the model group, FA down-regulatedphospho-mitogen activated protein kinase, phospho-extracellular signal regulated kinase1/2, myosin light chain kinase, and phospho-myosin regulatory light chain protein levels. Thus, FA ameliorated FD by regulating the Fc epsilon RI signaling pathway. Our integrated strategy identified underlying FA mechanisms toward FD treatment and provided a foundation for FA development as a clinical agent for FD.

The intestinal delivery systems of ferulic acid: Absorption, metabolism, influencing factors, and potential applications

A Review: Interactions Between Protein from Blue Foods and Functional Components in Delivery Systems: Function Exertion and Transmembrane Transport by in Vitro Digestion/cells Model

Ferulic Acid: A Comprehensive Review

The Antioxidant Properties, Metabolism, Application and Mechanism of Ferulic Acid in Medicine, Food, Cosmetics, Livestock and Poultry

Recent Advances in Biological Activity, New Formulations and Prodrugs of Ferulic Acid

Ferulic Acid as a Protective Antioxidant of Human Intestinal Epithelial Cells

Ferulic Acid: A Review of Pharmacology, Toxicology, and Therapeutic Effects on Pulmonary Diseases

Ferulic acid: extraction, estimation, bioactivity and applications for human health and food

Ferulic acid: A review of its pharmacology, pharmacokinetics and derivatives

Ferulic Acid Derivatives Ameliorate Intestine Barrier Destruction by Alleviating Inflammatory Responses in Dextran Sulfate Sodium-Induced Inflammatory Bowel Disease

Ferulic Acid—A Brief Review of Its Extraction, Bioavailability and Biological Activity

Molecular mechanism and research progress on pharmacology of ferulic acid in liver diseases

Zein-casein-lysine multicomposite nanoparticles are effective in modulate the intestinal permeability of ferulic acid

Preparation and characterization of feruloylated oat β-glucan with antioxidant activity and colon-targeted delivery

Preparation, Characterization, and Evaluation of Liposomal Ferulic Acid in Vitro and in Vivo

Protective Effects of Ferulic Acid against Heat Stress-Induced Intestinal Epithelial Barrier Dysfunction In Vitro and In Vivo

Effects of Dietary Ferulic Acid on Intestinal Health and Ileal Microbiota of Tianfu Broilers Challenged with Lipopolysaccharide

Fructus Aurantii Extracts Ameliorate Intestinal Inflammation and Regulate the Intestinal Barrier Through Fc Epsilon RI Signaling Pathway

Ferulic Acid: A Promising Therapeutic phytochemical and recent patents advances.

Ferulic acid nanoemulsion as a promising anti-ulcer tool: in vitro and in vivo assessment

Ferulic acid's therapeutic odyssey: nano formulations, pre-clinical investigations, and patent perspective